Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Increasing preclinical and clinical evidence underscores the strong and rapid antidepressant properties of the glutamate-modulating NMDA receptor antagonist ketamine. Targeting the glutamatergic system might thus provide a novel molecular strategy for antidepressant treatment. Since glutamate is the most abundant and major excitatory neurotransmitter in the brain, pathophysiological changes in glutamatergic signaling are likely to affect neurobehavioral plasticity, information processing and large-scale changes in functional brain connectivity underlying certain symptoms of major depressive disorder. Using resting state functional magnetic resonance imaging (rsfMRI), the "dorsal nexus "(DN) was recently identified as a bilateral dorsal medial prefrontal cortex region showing dramatically increased depression-associated functional connectivity with large portions of a cognitive control network (CCN), the default mode network (DMN), and a rostral affective network (AN). Hence, Sheline and colleagues (2010) proposed that reducing increased connectivity of the DN might play a critical role in reducing depression symptomatology and thus represent a potential therapy target for affective disorders. Here, using a randomized, placebo-controlled, double-blind, crossover rsfMRI challenge in healthy subjects we demonstrate that ketamine decreases functional connectivity of the DMN to the DN and to the pregenual anterior cingulate (PACC) and medioprefrontal cortex (MPFC) via its representative hub, the posterior cingulate cortex (PCC). These findings in healthy subjects may serve as a model to elucidate potential biomechanisms that are addressed by successful treatment of major depression. This notion is further supported by the temporal overlap of our observation of subacute functional network modulation after 24 hours with the peak of efficacy following an intravenous ketamine administration in treatment-resistant depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“That such changes of RSFC after interventions of antidepressant action can also be observed in healthy subjects was recently supported by a finding from Scheidegger and colleagues [68], who showed that, similar to our finding, a connectivity decrease of anterior and posterior DMN components, located in pgACC and PCC, was observed after 24 hrs of ketamine injection, mirroring the substances'”
From State and training effects of mindfulness meditation on brain networks reflect neuronal mechanisms of its antidepressant effect (2016) · cites this paper as [68]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These findings were complemented by data showing that 8 weeks of sertraline treatment normalized amygdalar hyper-activation to sad faces in MDD [194], replicating prior findings [195,196].”
From Prefrontal cortex and depression (2022) · cites this paper as [194]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1970) · Cited by 24,983
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319 · cited 1×
“Since in a recent study, decreased connectivity of the amygdala to prefrontal areas has been shown following antidepressant treatment [48], we further included anatomically defined ROIs for left and right amygdala, taken from the Automated Anatomical Labeling (AAL) atlas [55].”
MethodA default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190 · cited 2×
“Specifically in depressed patients, altered negative BOLD responses in the default mode network (DMN) [37] could be found during emotional processing tasks [38,39], with decreased negative BOLD signal amplitudes being positively correlated with lower glutamate concentrations within the pregenual anterior cingulate cor…”
BackgroundThe Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · cited 1×
“Moreover, the sgACC as a critical hub of the AN plays an important role in emotion processing and the pathogenesis of mood disorders and has become a promising target for deep brain stimulation in patients with severe, refractory depression [65].”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“Based on the increasing evidence of glutamate-modulating agents having strong and rapid antidepressant properties [1,2], the NMDA receptor antagonist ketamine has been firmly established as a research tool for the investigation of the neurobiology of the glutamatergic system in major depressive disorder (MDD) and nove…”
BackgroundA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
DPARSF: a MATLAB toolbox for “pipeline” data analysis of resting-state fMRI
Yan (2010) · Frontiers in System Neuroscience · doi:10.3389/fnsys.2010.00013 · Cited by 3,475
Functional and Effective Connectivity: A Review
Friston, K. J. (2011) · Brain Connectivity · doi:10.1089/brain.2011.0008 · Cited by 3,415 · cited 1×
“Recent advances in resting state functional connectivity neuroimaging techniques suggest their utility for the investigation of (1) intrinsic brain connections in the healthy human brain, (2) pathophysiological alterations in disease states and (3) changes in neuronal network dynamics following therapeutic interventio…”
BackgroundInfluentialmTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
STAI manual for the State-trait anxiety inventory
Cd, S. (1970) · Medical Entomology and Zoology · Cited by 2,492
Manual for the state-trait anxiety inventory (form Y) : "self-evaluation questionnaire"
Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E. (1970) · Consulting Psychologists Press eBooks · Cited by 2,352
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 1×
“In general, we hypothesize that the therapeutic potential of ketamine may be explained by reversing disturbances in the glutamatergic system [12] and thus restore parts of a disrupted neurobehavioral homeostasis in MDD, where several structural, metabolic, and functional abnormalities have been described previously [1…”
BackgroundGreicius, M. D., Flores, B. H., Menon, V., Glover, G. H., Solvason, H. B., Kenna, H., Reiss, A. L., & Schatzberg, A. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.020 · Cited by 2,214 · cited 3×
“Resting state sgACC functional connectivity with the DMN was significantly greater in depressed subjects and correlated positively with the length of the current depressive episode [44].”
BackgroundMethodResultNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 1×
“Although its exact mechanism of action is still unknown, various neuronal and molecular pathways have been investigated in animal models and are proposed to critically mediate its antidepressant effects [8–11].”
BackgroundREST: A Toolkit for Resting-State Functional Magnetic Resonance Imaging Data Processing
Song, X.-W., Dong, Z.-Y., Long, X.-Y., Li, S.-F., Zuo, X.-N., Zhu, C.-Z., He, Y., Yan, C.-G., & Zang, Y.-F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025031 · Cited by 1,872 · cited 1×
“[54]).”
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · cited 1×
“This notion is further supported by several findings at different levels of neuronal organization, demonstrating beneficial effects of ketamine on glutamatergic signaling [24–28], AMPA-to-NMDA-receptor throughput [11,29], intracellular signaling [8,10], and neurotrophic factors [30,31].”
ResultA scale for the assessment of hedonic tone the Snaith-Hamilton pleasure scale
Snaith, R. P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., & Trigwell, P. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.1.99 · Cited by 1,778 · cited 4×
“There was no significant correlation between psychotomimetic side effects and changes in functional connectivity of the AN und DMN seed regions to the DN. Ketamine or placebo treatment also did not affect subjective state and mood measured over the experimental period using the STAI X1 [51] and the Snaith-Hamilton Ple…”
MethodInfluentialNeurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606 · cited 1×
“Seed region selection We limited our analysis to a priori determined seed regions based on functional-anatomical network hypotheses and fMRI studies that yielded differential patterns of functional activation and connectivity in depressed patients and healthy subjects [21,44,46,48].”
MethodLimbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585 · cited 1×
“depressed state can be characterized by the tendency to enter and to remain in an inappropriate mode of information processing in limbic-cortico-striato-pallido-thalamic circuits that subserve the regulation of mood [21–23].”
BackgroundThe default mode network and self-referential processes in depression
Sheline, Y. I., Barch, D. M., Price, J. L., Rundle, M. M., Vaishnavi, S. N., Snyder, A. Z., Mintun, M. A., Wang, S., Coalson, R. S., & Raichle, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812686106 · Cited by 1,480 · cited 2×
“within the DMN during external stimulation was found [38,39], with increasing levels of DMN dominance being associated with higher levels of maladaptive, depressive rumination and lower levels of adaptive, reflective rumination [64].”
BackgroundNew insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · cited 1×
“This notion is further supported by several findings at different levels of neuronal organization, demonstrating beneficial effects of ketamine on glutamatergic signaling [24–28], AMPA-to-NMDA-receptor throughput [11,29], intracellular signaling [8,10], and neurotrophic factors [30,31].”
ResultSheline, Y. I., Price, J. L., Yan, Z., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000446107 · Cited by 1,196 · cited 6×
“Seed region selection We limited our analysis to a priori determined seed regions based on functional-anatomical network hypotheses and fMRI studies that yielded differential patterns of functional activation and connectivity in depressed patients and healthy subjects [21,44,46,48].”
BackgroundMethodInfluentialClinical applications of resting state functional connectivity
Fox, M. D. (2010) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2010.00019 · Cited by 1,167
The subgenual anterior cingulate cortex in mood disorders
Drevets, W. C., Savitz, J., & Trimble, M. (2008) · CNS Spectrums · doi:10.1017/s1092852900013754 · Cited by 1,109 · cited 2×
“A number of structural, metabolic and functional abnormalities has been identified in the sgACC of MDD patients [66].”
BackgroundMaeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
Li, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894 · cited 2×
“Since glutamate is the most abundant and major excitatory neurotransmitter in the human brain, pathophysiological changes in glutamatergic signaling associated with chronic stress exposure and disease progression emerge as a powerful explanatory framework to integrate the observed findings into a comprehensive disease…”
BackgroundHamilton, J. P., Furman, D. J., Chang, C., Thomason, M. E., Dennis, E., & Gotlib, I. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.003 · Cited by 823 · cited 1×
“within the DMN during external stimulation was found [38,39], with increasing levels of DMN dominance being associated with higher levels of maladaptive, depressive rumination and lower levels of adaptive, reflective rumination [64].”
BackgroundAnand, A., Li, Y., Wang, Y., Wu, J., Gao, S., Bukhari, L., Mathews, V. P., Kalnin, A., & Lowe, M. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.021 · Cited by 787 · cited 1×
“Several dysfunctions in cortico-limbic neurocircuits [43,44] as well as task-positive and task-negative systems [45] have been reported in previous studies of resting state functional connectivity in depressed patients.”
ResultCotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.545 · Cited by 766 · cited 1×
“In general, we hypothesize that the therapeutic potential of ketamine may be explained by reversing disturbances in the glutamatergic system [12] and thus restore parts of a disrupted neurobehavioral homeostasis in MDD, where several structural, metabolic, and functional abnormalities have been described previously [1…”
BackgroundThe neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723 · cited 1×
“Based on the increasing evidence of glutamate-modulating agents having strong and rapid antidepressant properties [1,2], the NMDA receptor antagonist ketamine has been firmly established as a research tool for the investigation of the neurobiology of the glutamatergic system in major depressive disorder (MDD) and nove…”
BackgroundSafety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
aan het Rot, M., Collins, K. A., Murrough, J. W., Perez, A. M., Reich, D. L., Charney, D. S., & Mathew, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.038 · Cited by 690
Choudary, P. V., Molnar, M., Evans, S. J., Tomita, H., Li, J. Z., Vawter, M. P., Myers, R. M., Bunney, W. E., Akil, H., Watson, S. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507901102 · Cited by 652 · cited 1×
“In general, we hypothesize that the therapeutic potential of ketamine may be explained by reversing disturbances in the glutamatergic system [12] and thus restore parts of a disrupted neurobehavioral homeostasis in MDD, where several structural, metabolic, and functional abnormalities have been described previously [1…”
BackgroundThe Neural Correlates of Anhedonia in Major Depressive Disorder
Keedwell, P. A., Andrew, C., Williams, S. C. R., Brammer, M. J., & Phillips, M. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.019 · Cited by 650 · cited 1×
“In general, we hypothesize that the therapeutic potential of ketamine may be explained by reversing disturbances in the glutamatergic system [12] and thus restore parts of a disrupted neurobehavioral homeostasis in MDD, where several structural, metabolic, and functional abnormalities have been described previously [1…”
BackgroundThe Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577 · cited 2×
“Psychometric measures Compared to placebo, subjects reported a significant increase in psychotomimetic symptoms following ketamine administration as assessed by the 5D-ASC questionnaire [50].”
MethodMuthukumaraswamy, S. D., Edden, R. A. E., Jones, D. K., Swettenham, J. B., & Singh, K. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900728106 · Cited by 567
Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders
Yüksel, C., & Öngür, D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.016 · Cited by 493 · cited 2×
“In general, we hypothesize that the therapeutic potential of ketamine may be explained by reversing disturbances in the glutamatergic system [12] and thus restore parts of a disrupted neurobehavioral homeostasis in MDD, where several structural, metabolic, and functional abnormalities have been described previously [1…”
BackgroundGarcia, L. S. B., Comim, C. M., Valvassori, S. S., Réus, G. Z., Barbosa, L. M., Andreazza, A. C., Stertz, L., Fries, G. R., Gavioli, E. C., Kapczinski, F., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.027 · Cited by 454 · cited 1×
“This notion is further supported by several findings at different levels of neuronal organization, demonstrating beneficial effects of ketamine on glutamatergic signaling [24–28], AMPA-to-NMDA-receptor throughput [11,29], intracellular signaling [8,10], and neurotrophic factors [30,31].”
ResultLorrain, D. S., Baccei, C. S., Bristow, L. J., Anderson, J. J., & Varney, M. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00652-8 · Cited by 432 · cited 1×
“This notion is further supported by several findings at different levels of neuronal organization, demonstrating beneficial effects of ketamine on glutamatergic signaling [24–28], AMPA-to-NMDA-receptor throughput [11,29], intracellular signaling [8,10], and neurotrophic factors [30,31].”
ResultStuck in a rut: rethinking depression and its treatment
Holtzheimer, P. E., & Mayberg, H. S. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.10.004 · Cited by 430 · cited 1×
“depressed state can be characterized by the tendency to enter and to remain in an inappropriate mode of information processing in limbic-cortico-striato-pallido-thalamic circuits that subserve the regulation of mood [21–23].”
BackgroundGABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI
Northoff, G., Walter, M., Schulte, R. F., Beck, J., Dydak, U., Henning, A., Boeker, H., Grimm, S., & Boesiger, P. (2007) · Nature Neuroscience · doi:10.1038/nn2001 · Cited by 359 · cited 1×
“Multimodal imaging studies combining MR spectroscopy and fMRI raised the interest for the investigation of the neurochemical basis of blood oxygen level-dependent (BOLD) signal fluctuations during activity [17,33,34] and at rest [35,36].”
BackgroundSelf-citationGrimm, S., Boesiger, P., Beck, J., Schuepbach, D., Bermpohl, F., Walter, M., Ernst, J., Hell, D., Boeker, H., & Northoff, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.81 · Cited by 350 · cited 2×
“within the DMN during external stimulation was found [38,39], with increasing levels of DMN dominance being associated with higher levels of maladaptive, depressive rumination and lower levels of adaptive, reflective rumination [64].”
BackgroundSelf-citationSinner, B., & Graf, B. M. (2008) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-74806-9_15 · Cited by 313
Walter, M., Henning, A., Grimm, S., Schulte, R. F., Beck, J., Dydak, U., Schnepf, B., Boeker, H., Boesiger, P., & Northoff, G. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.39 · Cited by 306 · cited 11×
“A current investigation by Salvadore et al. (2009) importantly revealed magnetoencephalographic activation in the PACC to be predictive of subsequent treatment response to ketamine in MDD, thus providing a link between ketamine efficacy and glutamatergic dysfunction in the ACC [40].”
BackgroundInfluentialSelf-citationRowland, L. M., Bustillo, J. R., Mullins, P. G., Jung, R. E., Lenroot, R., Landgraf, E., Barrow, R., Yeo, R., Lauriello, J., & Brooks, W. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.394 · Cited by 304
Stone, J. M., Dietrich, C., Edden, R., Mehta, M. A., De Simoni, S., Reed, L. J., Krystal, J. H., Nutt, D., & Barker, G. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.171 · Cited by 295 · cited 1×
“This notion is further supported by several findings at different levels of neuronal organization, demonstrating beneficial effects of ketamine on glutamatergic signaling [24–28], AMPA-to-NMDA-receptor throughput [11,29], intracellular signaling [8,10], and neurotrophic factors [30,31].”
ResultSalvadore, G., Cornwell, B. R., Colon-Rosario, V., Coppola, R., Grillon, C., Zarate, C. A., & Manji, H. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.014 · Cited by 277
Horn (2010) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2010.00033 · Cited by 276
Ketamine and the next generation of antidepressants with a rapid onset of action
Machado-Vieira, R., Salvadore, G., DiazGranados, N., & Zarate, C. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.010 · Cited by 276 · cited 1×
“Based on the increasing evidence of glutamate-modulating agents having strong and rapid antidepressant properties [1,2], the NMDA receptor antagonist ketamine has been firmly established as a research tool for the investigation of the neurobiology of the glutamatergic system in major depressive disorder (MDD) and nove…”
BackgroundChana, G., Landau, S., Beasley, C., Everall, I. P., & Cotter, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00114-8 · Cited by 246 · cited 1×
“In general, we hypothesize that the therapeutic potential of ketamine may be explained by reversing disturbances in the glutamatergic system [12] and thus restore parts of a disrupted neurobehavioral homeostasis in MDD, where several structural, metabolic, and functional abnormalities have been described previously [1…”
BackgroundA role for AMPA receptors in mood disorders
Alt, A., Nisenbaum, E. S., Bleakman, D., & Witkin, J. M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.022 · Cited by 238 · cited 1×
“This notion is further supported by several findings at different levels of neuronal organization, demonstrating beneficial effects of ketamine on glutamatergic signaling [24–28], AMPA-to-NMDA-receptor throughput [11,29], intracellular signaling [8,10], and neurotrophic factors [30,31].”
ResultIncreased neural resources recruitment in the intrinsic organization in major depression
Zhou, Y., Yu, C., Zheng, H., Liu, Y., Song, M., Qin, W., Li, K., & Jiang, T. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.05.029 · Cited by 228 · cited 1×
“Several dysfunctions in cortico-limbic neurocircuits [43,44] as well as task-positive and task-negative systems [45] have been reported in previous studies of resting state functional connectivity in depressed patients.”
ResultPhelps, L. E., Brutsche, N., Moral, J. R., Luckenbaugh, D. A., Manji, H. K., & Zarate, C. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.029 · Cited by 189 · cited 1×
“Based on the increasing evidence of glutamate-modulating agents having strong and rapid antidepressant properties [1,2], the NMDA receptor antagonist ketamine has been firmly established as a research tool for the investigation of the neurobiology of the glutamatergic system in major depressive disorder (MDD) and nove…”
BackgroundMcCabe, C., & Mishor, Z. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.05.051 · Cited by 184
Bechtholt-Gompf, A. J., Walther, H. V., Adams, M. A., Carlezon, W. A., Öngür, D., & Cohen, B. M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.74 · Cited by 152
Portella, M. J., de Diego-Adeliño, J., Gómez-Ansón, B., Morgan-Ferrando, R., Vives, Y., Puigdemont, D., Pérez-Egea, R., Ruscalleda, J., Álvarez, E., & Pérez, V. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.08.010 · Cited by 127 · cited 1×
“In general, we hypothesize that the therapeutic potential of ketamine may be explained by reversing disturbances in the glutamatergic system [12] and thus restore parts of a disrupted neurobehavioral homeostasis in MDD, where several structural, metabolic, and functional abnormalities have been described previously [1…”
BackgroundSSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex
McCabe, C., Mishor, Z., Filippini, N., Cowen, P. J., Taylor, M. J., & Harmer, C. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.138 · Cited by 123 · cited 1×
“The hypothesis that decreasing the activity of the DN might be a potential marker of antidepressant drug intervention was tested in a recent study in healthy subjects, showing reduced connectivity between the left DN seed region and the left hippocampus after selective serotonin reuptake inhibitor (SSRI) administratio…”
BackgroundKetamine alters neural processing of facial emotion recognition in healthy men: an fMRI study
Abel, K. M., Allin, M. P. G., Kucharska-Pietura, K., David, A., Andrew, C., Williams, S., Brammer, M. J., & Phillips, M. L. (2003) · NeuroReport · doi:10.1097/00001756-200303030-00018 · Cited by 109
Honey, R. A. E., Honey, G. D., O'Loughlin, C., Sharar, S. R., Kumaran, D., Bullmore, E. T., Menon, D. K., Donovan, T., Lupson, V. C., Bisbrown-Chippendale, R., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300438 · Cited by 102 · cited 1×
“While pharmacological effects of ketamine on task-induced fMRI BOLD signals have been studied extensively [56–62], this is the first randomized, placebo-controlled, double-blind, crossover study demonstrating changes in resting state functional connectivity in response to ketamine administration in healthy subjects.”
BackgroundKetamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task
Musso, F., Brinkmeyer, J., Ecker, D., London, M. K., Thieme, G., Warbrick, T., Wittsack, H., Saleh, A., Greb, W., de Boer, P., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.06.045 · Cited by 89
Targeting glial physiology and glutamate cycling in the treatment of depression
Valentine, G. W., & Sanacora, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.008 · Cited by 87 · cited 1×
“In conclusion, those findings indicate that ketamine may have a stimulating effect on overall glutamateglutamine-cycling, which is supposed to be reduced in MDD [12,17,32].”
BackgroundNorthoff, G., Richter, A., Bermpohl, F., Grimm, S., Martin, E., Marcar, V. L., Wahl, C., Hell, D., & Boeker, H. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.04.009 · Cited by 87 · cited 1×
“While pharmacological effects of ketamine on task-induced fMRI BOLD signals have been studied extensively [56–62], this is the first randomized, placebo-controlled, double-blind, crossover study demonstrating changes in resting state functional connectivity in response to ketamine administration in healthy subjects.”
BackgroundSelf-citationDuncan, N. W., Enzi, B., Wiebking, C., & Northoff, G. (2011) · Human Brain Mapping · doi:10.1002/hbm.21179 · Cited by 68 · cited 1×
“Multimodal imaging studies combining MR spectroscopy and fMRI raised the interest for the investigation of the neurochemical basis of blood oxygen level-dependent (BOLD) signal fluctuations during activity [17,33,34] and at rest [35,36].”
BackgroundKim, S., Lee, H., Kim, H., Bang, E., Lee, S., Lee, D., Woo, D., Choi, C., Hong, K. S., Lee, C., et al. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1681 · Cited by 63
Abel, K. M., Allin, M. P. G., Kucharska‐Pietura, K., Andrew, C., Williams, S., David, A. S., & Phillips, M. L. (2003) · Human Brain Mapping · doi:10.1002/hbm.10064 · Cited by 55 · cited 1×
“While pharmacological effects of ketamine on task-induced fMRI BOLD signals have been studied extensively [56–62], this is the first randomized, placebo-controlled, double-blind, crossover study demonstrating changes in resting state functional connectivity in response to ketamine administration in healthy subjects.”
BackgroundFu, C. H. Y., Abel, K. M., Allin, M. P. G., Gasston, D., Costafreda, S. G., Suckling, J., Williams, S., & McGuire, P. K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0154-9 · Cited by 54 · cited 1×
“While pharmacological effects of ketamine on task-induced fMRI BOLD signals have been studied extensively [56–62], this is the first randomized, placebo-controlled, double-blind, crossover study demonstrating changes in resting state functional connectivity in response to ketamine administration in healthy subjects.”
BackgroundNeural correlates of S-ketamine induced psychosis during overt continuous verbal fluency
Nagels, A., Kirner-Veselinovic, A., Krach, S., & Kircher, T. T. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.08.021 · Cited by 39 · cited 1×
“While pharmacological effects of ketamine on task-induced fMRI BOLD signals have been studied extensively [56–62], this is the first randomized, placebo-controlled, double-blind, crossover study demonstrating changes in resting state functional connectivity in response to ketamine administration in healthy subjects.”
Background
Cited by
Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026
“Studies in healthy controls are also consistent with the hypothesis that ketamine enhances GABA inhibition, reporting that ketamine decreases DMN connectivity and reduces reactivity of amygdala-hippocampal circuity in response to emotional stimuli (Evans et al., 2018; Scheidegger et al., 2016; Scheidegger et al., 2012…”
ResultPrefrontal cortex and depression
Pizzagalli, D. A., & Roberts, A. C. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01101-7 · Cited by 667
“These findings were complemented by data showing that 8 weeks of sertraline treatment normalized amygdalar hyper-activation to sad faces in MDD [194], replicating prior findings [195, 196].”
ResultPsilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13282-7 · Cited by 587
Functional reorganization of the default mode network across chronic pain conditions
Baliki, M. N., Mansour, A. R., Baria, A. T., & Apkarian, A. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106133 · Cited by 532
“For example, it has been shown that ketamine (an anti-depressant drug) decreases functional connectivity of the DMN to the MPFC in healthy subjects [55].”
BackgroundDepression, Neuroimaging and Connectomics: A Selective Overview
Gong, Q., & He, Y. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.009 · Cited by 496
“was tested by R-fMRI studies in healthy individuals: the MPFC exhibited reduced functional connectivity following a ketamine and SSRI (citalopram) administration (121-123).”
Metadata
- Authors
- Scheidegger, M., Walter, M., Lehmann, M., Metzger, C., Grimm, S., Boeker, H., Boesiger, P., Henning, A., & Seifritz, E.
- Affiliations
- ETH Zurich (CH)
- Center for Behavioral Brain Sciences (DE)
- Psychiatrische Universitätsklinik Zürich (CH)
- University of Zurich (CH)
- Corresponding author
- Scheidegger, Milan
- Walter, Martin
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-24
- Volume
- 7
- Issue
- 9
- Pages
- e44799
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3461985
- OpenAlex
- W1964807622
- Cited by
- 282
- References
- 68
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 16 · 2023: 13 · 2022: 19 · 2021: 21 · 2020: 13 · 2019: 26 · 2018: 21 · 2017: 17 · 2016: 36 · 2015: 25 · 2014: 27 · 2013: 18
- FWCI
- 16.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- ETH Zürich Research Collection (cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Keywords
- ketamine, resting-state functional connectivity, major depressive disorder, default mode network, posterior cingulate cortex, pregenual anterior cingulate cortex, glutamatergic system, NMDA receptor antagonists, antidepressant mechanism, treatment-resistant depression, cognitive control network
- MeSH terms
- Adult, Antidepressive Agents, Brain Mapping, Major Depressive Disorder, Double-Blind Method, Female, Gyrus Cinguli, Humans, Injections, Intravenous, Ketamine, Magnetic Resonance Imaging, Male, Middle Aged, Neural Pathways, Placebos, Septal Nuclei, Prefrontal Cortex, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.